Heartland Research Associates, LLC
Augusta, Kansas, United States
Research institute in Augusta, Kansas
1601 State St, Augusta, KS 67010
About Heartland Research Associates, LLC
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Pfizer
9
Bausch Health Americas, Inc.
2
Eli Lilly and Company
2
Ferring Pharmaceuticals
2
Bavarian Nordic
1
Elcelyx Therapeutics, Inc.
1
Emergent BioSolutions
1
Intarcia Therapeutics
1
Janssen Vaccines & Prevention B.V.
1
Mead Johnson Nutrition
1
Sol-Gel Technologies, Ltd.
1
Clinical Trials at Heartland Research Associates, LLC
During the past decade, Heartland Research Associates, LLC conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 19 clinical trials were completed, i.e. on
average, 135.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 9 clinical trials were completed. i.e. 900%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Trial to Evaluate Immunogenicity and Safety of Three Consecutive Production Lots of IMVAMUNE® (MVA-BN®) Smallpox Vaccine in Healthy, Vaccinia-naïve Subjects
2013-02-01
2014-06-01
Completed
4,005
The Plecanatide Chronic Idiopathic Constipation (CIC) Study
2011-10-01
2012-12-01
Completed
951
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
2011-09-28
2014-05-08
Completed
2,648
Duration of hSBA Response After a Primary Series of Bivalent rLP2086 Followed by a Booster Dose
2012-09-07
2018-01-05
Completed
698
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
2012-11-01
2014-10-01
Completed
428
A Trial to Assess the Lot Consistency, Safety, Tolerability and Immunogenicity of Bivalent rLP2086 Vaccine When Given to Healthy Subjects Aged ≥10 to <19 Years
2013-04-01
2015-04-01
Completed
3,596
Efficacy and Safety Trial of Elobixibat in Patients With Chronic Idiopathic Constipation
2013-04-01
2014-04-01
Terminated
314
Study Evaluating the Safety, Tolerability, and Efficacy of Dexmecamylamine (TC-5214) for Treatment of Overactive Bladder
2013-05-01
2014-06-01
Completed
1,635
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Heartland Research Associates, LLC" #1 sponsor was "Pfizer" with 9 trials, followed by "Bausch Health Americas, Inc." with 2 trials
sponsored, "Eli Lilly and Company" with 2 trials sponsored, "Ferring Pharmaceuticals" with 2 trials sponsored and "Bavarian Nordic"
with 2 trials sponsored. Other sponsors include 3 different institutions and
companies that sponsored additional 13 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Heartland Research Associates, LLC"
#1 collaborator was "CoLucid Pharmaceuticals" with 2 trials as a collaborator, "Accelovance" with 1 trials as a collaborator, "Biomedical Advanced Research and Development Authority" with 1 trials as a collaborator and "Parexel" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Heartland Research Associates, LLC
According to Clinical.Site data, the most researched conditions in "Heartland Research Associates, LLC" are
"Chronic Idiopathic Constipation" (3 trials), "Migraine, With or Without Aura" (3 trials), "Acne Vulgaris" (1 trials), "Anthrax" (1 trials) and "Dengue Fever" (1 trials). Many other conditions were trialed in "Heartland Research Associates, LLC" in a lesser frequency.
Clinical Trials Intervention Types at Heartland Research Associates, LLC
Most popular intervention types in "Heartland Research Associates, LLC" are "Drug" (15 trials), "Biological" (8 trials), "Other" (4 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (13 trials), "Rimegepant" (3 trials), "AV7909" (1 trials), "Adenovirus serotype 26 (Ad26)-based respiratory syncytial virus (RSV). preF" (1 trials) and "BioThrax" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Heartland Research Associates, LLC
The vast majority of trials in "Heartland Research Associates, LLC" are
24 trials for "All" genders.
Clinical Trials Status at Heartland Research Associates, LLC
Currently, there are NaN active trials in "Heartland Research Associates, LLC".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 21 completed trials in Heartland Research Associates, LLC,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Heartland Research Associates, LLC, 0 "Phase 1"
clinical trials were conducted, 9 "Phase 2" clinical
trials and 16 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".